Edwards Lifesciences Corporation logo
EWEdwards Lifesciences Corporation

Is the tax rate high or low?

The tax rate of 17.06% is 27% above its 5-year average of 13.42%, around the middle of its 5-year range (5.23%–28.98%).

9.66% below its 12-month average of 18.88%.

Tax Rate

EW Tax Rate

17.06%

Reported quarterly effective tax rate; periods with non-meaningful pretax income are omitted.

+66.17% 5Y
EW Tax Rate

EW Average Tax Rate Chart

EW Tax Rate

EW Current vs Average Tax Rate Chart

EW Tax Rate Metrics

TAX RATE

17.06%

TAX RATE AVG TTM

18.88%

TAX RATE AVG 3Y

12.49%

TAX RATE AVG 5Y

12.65%

TAX RATE AVG 10Y

14.05%

TAX RATE AVG 15Y

17.01%

TAX RATE AVG 20Y

18.36%

CURRENT VS TTM AVG

-9.66%

CURRENT VS 3Y AVG

+36.61%

CURRENT VS 5Y AVG

+34.89%

CURRENT VS 10Y AVG

+21.44%

CURRENT VS 15Y AVG

+0.28%

CURRENT VS 20Y AVG

-7.10%

Tax Rate Formula & Definition

Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Tax Rate FAQ

What is the tax rate for Edwards Lifesciences Corporation (EW)?
The tax rate for EW stock is 17.06%.
Is Edwards Lifesciences Corporation's tax rate high or low?
The tax rate of 17.06% is 27% above its 5-year average of 13.42%, around the middle of its 5-year range (5.23%–28.98%).
What is the TTM average tax rate for Edwards Lifesciences Corporation (EW)?
The TTM average tax rate for EW stock is 18.88%.
What is the 3Y average tax rate for Edwards Lifesciences Corporation (EW)?
The 3Y average tax rate for EW stock is 12.49%.
What is the 5Y average tax rate for Edwards Lifesciences Corporation (EW)?
The 5Y average tax rate for EW stock is 12.65%.
What is the 10Y average tax rate for Edwards Lifesciences Corporation (EW)?
The 10Y average tax rate for EW stock is 14.05%.
What is the 15Y average tax rate for Edwards Lifesciences Corporation (EW)?
The 15Y average tax rate for EW stock is 17.01%.
What is the 20Y average tax rate for Edwards Lifesciences Corporation (EW)?
The 20Y average tax rate for EW stock is 18.36%.

EW Tax Rate History

DATETAX RATE
2026-03-3117.06%
2025-12-3128.98%
2025-09-3016.10%
2025-06-3016.07%
2025-03-3116.20%
2024-12-3111.56%
2024-09-3010.10%
2024-06-305.23%
2024-03-3112.47%
2023-12-319.29%
2023-09-3013.60%
2023-06-307.60%
2023-03-3114.58%
2022-12-3113.26%
2022-09-3015.66%
2022-06-3012.55%
2022-03-3114.33%
2021-12-3110.90%
2021-09-3013.00%
2021-06-3010.27%
2021-03-3113.13%
2020-12-3113.09%
2020-09-3010.73%
2020-03-3114.79%
2019-12-3111.19%
2019-09-308.95%
2019-06-3010.69%
2019-03-3110.18%
2018-09-309.17%
2018-06-30-12.63%
2018-03-3121.59%
2017-12-31100.86%
2017-09-3019.69%
2017-06-309.48%
2017-03-3121.59%
2016-12-3120.91%
2016-09-3023.65%
2016-06-3025.09%
2016-03-3121.99%
2015-12-3115.75%
2015-09-3021.63%
2015-06-3020.75%
2015-03-3124.06%
2014-12-3117.83%
2014-09-3021.56%
2014-06-3032.73%
2014-03-3121.99%
2013-12-3125.32%
2013-09-3023.02%
2013-06-3022.74%
2013-03-3124.57%
2012-12-3125.45%
2012-09-3025.91%
2012-06-3024.58%
2012-03-3123.95%
2011-12-318.02%
2011-09-3010.42%
2011-06-3020.19%
2011-03-3124.47%
2010-12-317.56%
2010-09-3027.49%
2010-06-3013.40%
2010-03-3127.18%
2009-12-3123.72%
2009-09-3021.97%
2009-06-3024.36%
2009-03-3128.82%
2008-12-31-12.06%
2008-09-3024.54%
2008-06-3023.80%
2008-03-3147.55%
2007-12-3119.39%
2007-09-3025.00%
2007-06-3025.43%
2007-03-3125.56%
2006-12-3112.66%
2006-09-3024.25%
2006-06-3020.66%
2006-03-3131.82%
2005-12-3111.26%
2005-09-30128.76%
2005-06-309.15%
2005-03-3126.76%
2004-12-3124.05%
2004-09-3036.41%
2004-06-3025.22%
2003-12-3130.00%
2003-09-30-66.67%
2003-06-3027.24%
2003-03-3134.39%
2002-12-3125.94%
2002-06-3030.14%

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Irvine, CA
15,800 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian